Yuichi Sakamori
- Oncology top 2%
- Lung Cancer Research Studies 31
- Cancer Immunotherapy and Biomarkers 12
- Colorectal Cancer Treatments and Studies 9
-
- Lung Cancer Treatments and Mutations 45
- Lung Cancer Diagnosis and Treatment 14
- Brain Metastases and Treatment 6
-
- Cancer therapeutics and mechanisms 8
-
- Neuroendocrine Tumor Research Advances 8
- Co-authors
- Young Hak KimMichiaki MishimaYosuke TogashiKatsuhiro MasagoHiroki NagaiHiroaki OzasaTadashi MioMasahide Fukudo
- Journals
- Nature Communications (1 paper)Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- JapanItalyUnited States
In The Last Decade
Yuichi Sakamori
76 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 88
- Oncology 1.0k
- Pulmonary and Respiratory Medicine 932
- Cancer Research 146
- Genetics 70
- Immunology 114
Countries citing papers authored by Yuichi Sakamori
This map shows the geographic impact of Yuichi Sakamori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichi Sakamori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichi Sakamori more than expected).
Fields of papers citing papers by Yuichi Sakamori
This network shows the impact of papers produced by Yuichi Sakamori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichi Sakamori. The network helps show where Yuichi Sakamori may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuichi Sakamori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 14 | |
| 2 | 2020 | 5 | |
| 3 | 2020 | 1 | |
| 4 | 2020 | 4 | |
| 5 | 2020 | 32 | |
| 6 | 2020 | 57 | |
| 7 | 2019 | 105 | |
| 8 | 2018 | 41 | |
| 9 | 2017 | 9 | |
| 10 | 2016 | 10 | |
| 11 | 2016 | 2 | |
| 12 | 2013 | 35 | |
| 13 | 2013 | 11 | |
| 14 | 2012 | 5 | |
| 15 | 2011 | 4 | |
| 16 | 2011 | 15 | |
| 17 | 2011 | 26 | |
| 18 | 2010 | 55 | |
| 19 | 2010 | 42 | |
| 20 | 2010 | 6 |
About Yuichi Sakamori
Yuichi Sakamori is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Internal Medicine, having authored 81 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (45 papers), Lung Cancer Research Studies (31 papers), Lung Cancer Diagnosis and Treatment (14 papers), Cancer Immunotherapy and Biomarkers (12 papers), Colorectal Cancer Treatments and Studies (9 papers), Cancer therapeutics and mechanisms (8 papers), Neuroendocrine Tumor Research Advances (8 papers) and Brain Metastases and Treatment (6 papers). The work is most often cited by research in Oncology (1.0k citations), Pulmonary and Respiratory Medicine (932 citations) and Cancer Research (146 citations). Yuichi Sakamori has collaborated with scholars based in Japan, Italy and United States. Frequent co-authors include Young Hak Kim, Michiaki Mishima, Yosuke Togashi, Katsuhiro Masago, Hiroki Nagai, Hiroaki Ozasa, Tadashi Mio, Masahide Fukudo, Hironori Yoshida and Yasuaki Ikemi. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.